Cargando…
Successful treatment of proven coronavirus disease 2019-associated pulmonary aspergillosis with liposomal amphotericin B in a patient with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation
Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) is being increasingly recognized as a severe complication that contributes to poor prognoses among patients with COVID-19. However, little is known regarding the clinical course of CAPA with hematological malignancies, esp...
Autores principales: | Nakaya, Yosuke, Nakashima, Yasuhiro, Harada, Naonori, Yamada, Koichi, Makuuchi, Yosuke, Kuno, Masatomo, Takakuwa, Teruhito, Okamura, Hiroshi, Nanno, Satoru, Nishimoto, Mitsutaka, Koh, Hideo, Nakagama, Yu, Kido, Yasutoshi, Kanno, Takayuki, Suzuki, Tadaki, Nakamae, Hirohisa, Kakeya, Hiroshi, Hino, Masayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659359/ https://www.ncbi.nlm.nih.gov/pubmed/36379403 http://dx.doi.org/10.1016/j.jiac.2022.10.020 |
Ejemplares similares
-
A Prospective Study of an HLA-Haploidentical Peripheral Blood Stem Cell Transplantation Regimen Based on Modification of the Dose of Posttransplant Cyclophosphamide for Poor Prognosis or Refractory Hematological Malignancies
por: Nakamae, Hirohisa, et al.
Publicado: (2022) -
Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy
por: Okamura, Hiroshi, et al.
Publicado: (2021) -
Ibrutinib Induces a Dramatic Improvement for Idiopathic Refractory Ascites Following Allogeneic Hematopoietic Cell Transplantation
por: Tazoe, Kumiyo, et al.
Publicado: (2023) -
Successful management of therapy‐related chronic myelomonocytic leukemia with cytarabine, aclarubicin, and azacitidine following tegafur/gimeracil/oteracil
por: Nakako, Soichiro, et al.
Publicado: (2021) -
Acquired Gray Platelet Syndrome Associated with Primary Myelofibrosis
por: Ido, Kentaro, et al.
Publicado: (2020)